Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mind Medicine Mindmed Inc (MNMD)

Mind Medicine Mindmed Inc (MNMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,996
  • Shares Outstanding, K 37,571
  • Annual Sales, $ 0 K
  • Annual Income, $ -93,040 K
  • 60-Month Beta 2.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.85
Trade MNMD with:

Options Overview Details

View History
  • Implied Volatility 94.60% ( +4.17%)
  • Historical Volatility 88.55%
  • IV Percentile 10%
  • IV Rank 13.31%
  • IV High 308.20% on 08/18/22
  • IV Low 61.82% on 05/12/22
  • Put/Call Vol Ratio 0.11
  • Today's Volume 8,754
  • Volume Avg (30-Day) 1,538
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 86,262
  • Open Int (30-Day) 123,159

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.49
  • Number of Estimates 3
  • High Estimate -0.48
  • Low Estimate -0.50
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +18.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.64 +51.52%
on 01/09/23
4.05 -1.23%
on 02/06/23
+1.36 (+51.52%)
since 01/06/23
3-Month
2.12 +88.68%
on 12/29/22
4.05 -1.23%
on 02/06/23
+1.34 (+50.38%)
since 11/04/22
52-Week
2.12 +88.68%
on 12/29/22
22.20 -81.98%
on 02/10/22
-12.80 (-76.19%)
since 02/04/22

Most Recent Stories

More News
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END

CYBN.NE : 0.6000 (+3.45%)
MMED.NE : 5.4100 (+15.85%)
LOBEF : 0.0328 (+5.81%)
LOBE.CN : 0.0450 (+12.50%)
ATAI : 1.9300 (+3.21%)
CMPS : 10.25 (-0.29%)
CYBN : 0.4400 (unch)
MNMD : 4.00 (+15.61%)
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...

LOBE.CN : 0.0450 (+12.50%)
LOBEF : 0.0328 (+5.81%)
ATAI : 1.9300 (+3.21%)
CMPS : 10.25 (-0.29%)
CYBN : 0.4400 (unch)
MNMD : 4.00 (+15.61%)
MindMed Provides Corporate Update and 2023 Outlook

/CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel...

MNMD : 4.00 (+15.61%)
MindMed Provides Corporate Update and 2023 Outlook

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

MNMD : 4.00 (+15.61%)
3 Biotech Stocks Aiming to Reinvent Mental Health Treatment

Atai, Biogen, and Sage are working to develop new treatments for mental illness.

BIIB : 288.28 (+1.64%)
ESALY : 61.5100 (-2.11%)
ATAI : 1.9300 (+3.21%)
SAGE : 45.72 (+3.53%)
ARKK : 42.24 (-1.42%)
SEEL : 0.8799 (+4.49%)
CMPS : 10.25 (-0.29%)
MNMD : 4.00 (+15.61%)
CYBN : 0.4400 (unch)
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

MNMD : 4.00 (+15.61%)
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference

/CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel...

MNMD : 4.00 (+15.61%)
MindMed to Participate in the Jefferies London Healthcare Conference

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

MNMD : 4.00 (+15.61%)
MindMed to Participate in the Jefferies London Healthcare Conference

/CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel...

MNMD : 4.00 (+15.61%)
MindMed Reports Third Quarter 2022 Financial Results and Business Highlights

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

MNMD : 4.00 (+15.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 4.75
2nd Resistance Point 4.40
1st Resistance Point 4.20
Last Price 4.00
1st Support Level 3.65
2nd Support Level 3.30
3rd Support Level 3.10

See More

52-Week High 22.20
Fibonacci 61.8% 14.53
Fibonacci 50% 12.16
Fibonacci 38.2% 9.79
Last Price 4.00
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar